Hologic, Inc.   Report issue

For profit Phase 4
Founded: Bedford MA United States (1985)
Status: Left NME R&D (2009)

Organization Overview

First Clinical Trial
2009
NCT01165307
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2009

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Active Ingredients

Drugs in Phase 4 Trials (3)

estradiol (progynon depot) (1 trial)

naproxen (naprosyn) (1 trial)

norgestrel (Ovral) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Menorrhagia (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 1
  • # of Trial APIs: 3